Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0471 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0471 | 0.5 | 0.5 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0471 | 0.5 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0471 | 0.5 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0471 | 0.5 | 0.5 |
Echinococcus granulosus | carboxylesterase 5A | 0.0471 | 0.5 | 0.5 |
Echinococcus multilocularis | acetylcholinesterase | 0.0471 | 0.5 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.0471 | 0.5 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0471 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0471 | 0.5 | 0.5 |
Brugia malayi | Carboxylesterase family protein | 0.0471 | 0.5 | 0.5 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0471 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 22.93 uM | Cytotoxicity against human HCT8 cells after 24 hrs by MTT assay | ChEMBL. | 20598779 |
IC50 (functional) | = 23.15 uM | Cytotoxicity against human A2780 cells after 24 hrs by MTT assay | ChEMBL. | 20598779 |
IC50 (functional) | = 24.46 uM | Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay | ChEMBL. | 20598779 |
IC50 (functional) | = 28.9 uM | Cytotoxicity against human BGC823 cells after 24 hrs by MTT assay | ChEMBL. | 20598779 |
IC50 (functional) | = 37.94 uM | Cytotoxicity against human A549 cells after 24 hrs by MTT assay | ChEMBL. | 20598779 |
IC50 (functional) | = 67.23 uM | Cytotoxicity against human Bel7402 cells after 24 hrs by MTT assay | ChEMBL. | 20598779 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.